Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals - Wikidata - wikimedia - TriplyDB

Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals

Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals

http://www.wikidata.org/entity/Q34052838

about

Combination Therapy for Chronic Hepatitis B: Current Indications The 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy.Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART HIV, Hepatitis B, and Hepatitis C in Zambia.Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand.An update on the use of Atripla in the treatment of HIV in the United States.HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus-Infected U.S. Women.Phase diagrams map the properties of antiviral agents directed against hepatitis B virus core assembly Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus.Hepatitis B Virus-HIV Coinfection: Forgotten but Not Gone.The 2013 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans.HIV/hepatitis B virus co-infection: current challenges and new strategies.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiency virus/hepatitis B virus co-infected patients in Brazil.Outcomes in HIV/HBV-Coinfected Patients in the Tenofovir Era Are Greatly Affected by Immune Suppression.Treatment outcomes in a cohort of patients with chronic hepatitis B and human immunodeficiency virus co-infection in Mumbai, India.

P2860

Q24604492-61CBB846-627B-43BD-930F-AFF5E633EE58 Q26781379-90F3DBF1-93E4-4725-937D-56E6539B72B8 Q33676594-2444FCFC-5E82-43D6-A680-B215DC69B544 Q34024622-F8A652CA-93B4-4A04-9E1E-3F9D921192E4 Q34070485-9ED3FAB2-CEEC-464B-B42C-71E44B9D7ECF Q35183973-4DDAC9EC-1007-4105-B918-11BCD6293356 Q35200503-8E486F5E-3CF5-41EE-A29D-08A50E5405B6 Q35530299-BCDFC326-62C1-4532-80B4-FC78C27A19CC Q35557269-D719B47F-4808-49E5-A8CC-1C07D8EBADAA Q35685474-F695E222-8239-48A9-9CF7-3FBFAC96A408 Q36609717-533E5D7F-7C8E-466C-9848-A949E5C4F95E Q36667005-FE301133-E859-406E-9262-3C1E121B2F0C Q36956933-CB4A3208-4C4B-4F84-AA5F-4C87D79D86E2 Q37167046-AB1404DF-EB52-4133-8588-79202EB35061 Q37518294-17491FB4-25F6-49EA-9A05-04E01B5BB3B9 Q37630062-CAEB5BEC-FCEF-40E3-9004-EB767282DF27 Q39425755-5D492944-5869-4097-9D74-FDA051555400 Q39462690-82665A0D-C7C7-4517-B0AD-B7D6F4820E0A Q41208197-59CB6B96-81CD-4B86-950E-54B39E42AAFC Q42270170-4A43BB5A-AEC6-4655-98A7-213620092F17

P2860

Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals

http://www.wikidata.org/entity/Q34052838

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Combination HBV therapy is lin ...... HIV/HBV coinfected individuals

@ast

Combination HBV therapy is lin ...... HIV/HBV coinfected individuals

@en

Combination HBV therapy is lin ...... HIV/HBV coinfected individuals

@nl

type

label

Combination HBV therapy is lin ...... HIV/HBV coinfected individuals

@ast

Combination HBV therapy is lin ...... HIV/HBV coinfected individuals

@en

Combination HBV therapy is lin ...... HIV/HBV coinfected individuals

@nl

prefLabel

Combination HBV therapy is lin ...... HIV/HBV coinfected individuals

@ast

Combination HBV therapy is lin ...... HIV/HBV coinfected individuals

@en

Combination HBV therapy is lin ...... HIV/HBV coinfected individuals

@nl

P1433

Q34052838-004E6A0C-E456-49E3-B98D-7CB56B35F207

P1476

Q34052838-FA759845-8BD6-494B-A261-31897B52ADA8

P2093

Q34052838-03169278-31E2-4459-847B-51A8C387AC1A

Q34052838-075534BF-2973-468B-BBA4-0C3592CA6762

Q34052838-08ACF520-7143-40DB-8CA9-50786A32FF45

Q34052838-1711C598-BCF6-47B9-A8BE-9AA85C607D4B

Q34052838-1BFED403-21F1-4A38-808F-45FEB0A8AD2A

Q34052838-4B87C28D-9A6C-4610-BBD0-21E90BDC82C9

Q34052838-5E3CC592-90D7-4CB3-ADAA-CD558BCFD3D4

Q34052838-5E81325D-757B-43A9-92A7-482A7DDADF0B

Q34052838-75F2A6F3-A7AD-405B-8880-AFCDCEA988B0

Q34052838-806009AF-5DE9-4AA2-AFA4-2163A265AB23

P2860

Q34052838-02678CC6-39D7-4507-BC1D-B189A387FB5F

Q34052838-0D80DC0C-CAE6-43BC-8796-69C69AAB1DFA

Q34052838-385E1388-E8DD-4932-A859-E7B0745DD7C5

Q34052838-4660BDD0-226C-4C20-AB92-B23070095BE6

Q34052838-4C05A09E-61D0-4F9A-BB57-B19FC74E3B4C

Q34052838-60831B48-C3FD-48EC-A612-D9DDD4173845

Q34052838-62323CA8-DFF5-4E96-BE73-337B34FFDB1B

Q34052838-657C3066-C9D7-42EC-92D2-A03AFB035003

Q34052838-731F6D5B-C1EA-4A38-ABD9-8729700AA212

Q34052838-886FC955-1330-473E-A8D0-44BDC090A168

P304

Q34052838-B2A0720A-89D4-425A-81BB-07E7A2A4A432

P31

Q34052838-E53D9C8D-015C-44C4-AF09-6B84C65FF6D7

P356

Q34052838-D546725F-F798-4DE2-9AC0-9786D78903E9

P407

Q34052838-7A8FE657-BCB6-492C-ABAA-23ECFCCEE84E

P433

Q34052838-6B8DE6B2-4810-42AF-9F20-EB32918E0B12

P478

Q34052838-6DAB7C97-3AD7-4FAE-A19F-022BA035B757

P50

Q34052838-383DE26D-F0C7-4E7B-9383-E9AEA40A4DFC

P577

Q34052838-5DE2AF49-D358-4E2B-89F0-5740D06ED504

P698

Q34052838-6EF467C7-7F35-4094-8961-5A2300627F4E

P932

Q34052838-8309C2C6-2F18-4991-9983-9AB0A7D356F4

P356

QAD.0B013E32832B43F2

P1433

P1476

Combination HBV therapy is lin ...... HIV/HBV coinfected individuals

@en

P2093

Chloe L Thio

http://www.w3.org/2001/XMLSchema#string

Eric Seaberg

http://www.w3.org/2001/XMLSchema#string

Frances H Philp

http://www.w3.org/2001/XMLSchema#string

Gail V Matthews

http://www.w3.org/2001/XMLSchema#string

Gregory J Dore

http://www.w3.org/2001/XMLSchema#string

Joe Sasadeusz

http://www.w3.org/2001/XMLSchema#string

Pip Marks

http://www.w3.org/2001/XMLSchema#string

Scott Bowden

http://www.w3.org/2001/XMLSchema#string

Stephen Locarnini

http://www.w3.org/2001/XMLSchema#string

Yiwei Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic hepatitis B.

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.

Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.

Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity.

Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity.

Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.

BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis B virus infection (2005).

Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro.

P304

1707-1715

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E32832B43F2

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Sharon R. Lewin

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19584701

http://www.w3.org/2001/XMLSchema#string

P932

2918388

http://www.w3.org/2001/XMLSchema#string